Ensemble Therapeutics has entered into two-part research and development collaboration with Novartis for oral, macrocyclic inflammatory cytokine IL-17 antagonists and additional disease targets. The collaboration will leverage Ensemble's ...
Tags: Ensemble Therapeutics, Novartis